TrialInvestigational new drugs2025
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer.
Rui Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2025
this papercites it